Published in J Virol on November 01, 2001
A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol (2005) 1.59
Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol (2006) 1.50
Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol (2005) 1.47
Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol (2004) 1.43
Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog (2006) 1.34
Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle. J Virol (2006) 1.34
Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1. Cell Microbiol (2010) 1.11
Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS One (2008) 1.10
The major apoptotic pathway activated and suppressed by poliovirus. J Virol (2003) 1.08
Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein. J Virol (2009) 1.07
Inhibition of cellular protein secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One (2010) 1.07
Viral security proteins: counteracting host defences. Nat Rev Microbiol (2010) 1.05
The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. J Biol Chem (2012) 1.03
Bovine ephemeral fever rhabdovirus α1 protein has viroporin-like properties and binds importin β1 and importin 7. J Virol (2013) 1.02
Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother (2009) 1.01
Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death. J Virol (2008) 0.99
Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J Virol (2007) 0.97
Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. J Virol (2013) 0.96
The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J Virol (2013) 0.95
Analysis of poliovirus protein 3A interactions with viral and cellular proteins in infected cells. J Virol (2011) 0.95
Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A. J Virol (2003) 0.94
Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog (2009) 0.91
Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J Virol (2004) 0.89
Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase. J Virol (2007) 0.89
Foot-and-mouth disease virus 3C protease induces fragmentation of the Golgi compartment and blocks intra-Golgi transport. J Virol (2013) 0.88
Intracellular topology and epitope shielding of poliovirus 3A protein. J Virol (2004) 0.87
Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis. J Virol (2009) 0.87
Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. J Virol (2005) 0.85
A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol (2010) 0.85
Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol (2015) 0.85
Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo. Virology (2012) 0.84
Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol (2008) 0.82
Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis. J Virol (2011) 0.81
An inside job: subversion of the host secretory pathway by intestinal pathogens. Curr Opin Infect Dis (2010) 0.80
Evolution of poliovirus defective interfering particles expressing Gaussia luciferase. J Virol (2011) 0.80
Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev (2014) 0.79
Norovirus mechanisms of immune antagonism. Curr Opin Virol (2015) 0.79
Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog (2012) 0.79
2C Proteins of Enteroviruses Suppress IKKβ Phosphorylation by Recruiting Protein Phosphatase 1. J Virol (2016) 0.76
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
The pathophysiology of tumor necrosis factors. Annu Rev Immunol (1992) 8.38
Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc Natl Acad Sci U S A (1998) 6.73
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 6.23
Life, death, and the pursuit of apoptosis. Genes Dev (1996) 6.21
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
A novel domain within the 55 kd TNF receptor signals cell death. Cell (1993) 5.59
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 4.41
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Regulation of translation by poliovirus. Adv Virus Res (1987) 4.08
Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol (1990) 3.73
Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J (1995) 3.54
Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A (2000) 3.45
The clathrin endocytic pathway in viral infection. EMBO J (1998) 2.74
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett (1991) 2.61
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A (1997) 2.50
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A (2000) 2.38
A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J (1999) 2.30
Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol (1997) 2.28
Cytokines and immunity to viral infections. Immunol Rev (1997) 2.13
Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13
Golgi-disturbing agents. Histochem Cell Biol (1998) 2.12
Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol (1995) 1.88
The fight of viruses against apoptosis. Curr Opin Genet Dev (1998) 1.88
A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem (1997) 1.88
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature (1998) 1.87
Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol (1998) 1.84
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci U S A (2000) 1.78
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72
Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med (2000) 1.72
A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J (1995) 1.69
L20B cells simplify culture of polioviruses from clinical samples. J Med Virol (1999) 1.49
The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol (1997) 1.43
Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci U S A (1999) 1.42
Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem (1998) 1.40
Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol (1997) 1.37
The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc Natl Acad Sci U S A (1998) 1.36
Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol (2000) 1.36
Viral interference with apoptosis. Semin Cell Dev Biol (1998) 1.27
Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virology (1998) 1.22
Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J Biol Chem (1988) 1.19
Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle. J Virol (2000) 1.18
Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected]. J Immunol (1992) 1.16
Poliovirus protease 3C(pro) kills cells by apoptosis. Virology (2000) 1.13
Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J Biol Chem (1998) 1.13
Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol (1997) 1.09
Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol (1997) 1.08
Virus proteins that bind cytokines, chemokines or interferons. Curr Opin Immunol (1996) 1.05
Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J Virol (1998) 1.02
Responses of insect cells to baculovirus infection: protein synthesis shutdown and apoptosis. J Virol (1997) 1.01
Virus-encoded receptors for cytokines and chemokines. Semin Cell Dev Biol (1998) 0.99
Cleavage of eukaryotic translation initiation factor 4G by exogenously added hybrid proteins containing poliovirus 2Apro in HeLa cells: effects on gene expression. Mol Cell Biol (1999) 0.98
Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology (2000) 0.92
Poliovirus infection induces apoptosis in CaCo-2 cells. J Med Virol (1999) 0.90
M-T2: a poxvirus TNF receptor homologue with dual activities. Immunol Cell Biol (1996) 0.82
A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Cytokine (1997) 0.81
Qualitative and quantitative differences in the cellular responses mediated through Fas antigen and tumor necrosis factor receptor. J Interferon Cytokine Res (1996) 0.81
Identification of two forms (31-33 and 48 kD) of the urinary soluble p55 tumor necrosis factor receptor that are differentially N- and O-glycosylated. J Interferon Cytokine Res (1995) 0.79
The role of tumor necrosis factor in viral disease. Antiviral Res (1993) 0.79
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A (2001) 5.80
Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology (1989) 4.22
Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA. Cell (1992) 3.89
Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81
The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology (1985) 3.29
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev (2000) 2.84
Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus-specific proteins in a cell-free system from Krebs-2 cells. FEBS Lett (1978) 2.75
Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology (1988) 2.67
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J Virol (1994) 2.30
Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Res (1992) 2.04
The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology (1986) 1.98
Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95
Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary ('kissing') interactions. EMBO J (1996) 1.94
Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol (1995) 1.88
Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology (1987) 1.81
Starting window, a distinct element in the cap-independent internal initiation of translation on picornaviral RNA. J Mol Biol (1994) 1.72
Analysis of the functional significance of amino acid residues in the putative NTP-binding pattern of the poliovirus 2C protein. J Gen Virol (1992) 1.70
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol (2001) 1.67
Intertypic recombination in poliovirus: genetic and biochemical studies. Virology (1983) 1.65
c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene (2007) 1.59
Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J Mol Biol (1994) 1.59
Poly(C) sequence is located near the 5'-end of encephalomyocarditis virus RNA. Biochem Biophys Res Commun (1976) 1.58
Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J (2001) 1.56
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol (2000) 1.54
The fates of chicken nuclear lamin proteins during mitosis: evidence for a reversible redistribution of lamin B2 between inner nuclear membrane and elements of the endoplasmic reticulum. J Cell Biol (1988) 1.47
Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants. J Virol (1993) 1.42
The position of polypeptide G on the encephalomyocarditis virus polyprotein cleavage map. FEBS Lett (1983) 1.40
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene (1998) 1.40
Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol (1991) 1.39
Leader polypeptides encoded in the 5'-region of the encephalomyocarditis virus genome. FEBS Lett (1982) 1.39
Encephalomyocarditis virus-specific polypeptide p22 is involved in the processing of the viral precursor polypeptides. FEBS Lett (1979) 1.39
Tentative identification of RNA-dependent RNA polymerases of dsRNA viruses and their relationship to positive strand RNA viral polymerases. FEBS Lett (1989) 1.36
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene (2001) 1.36
Picornaviridae. Intervirology (1974) 1.36
Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene (2000) 1.35
Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem (2000) 1.31
Nonreplicative RNA recombination in poliovirus. J Virol (1999) 1.30
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res (1993) 1.27
Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence. Virology (1984) 1.26
A cell-free model of the encephalomyocarditis virus-induced inhibition of host cell protein synthesis. Virology (1978) 1.25
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways. Oncogene (2009) 1.24
Inhibition of activity of encephalomyocarditis virus-induced RNA polymerase by antibodies against cellular components. Virology (1979) 1.24
Early alteration of nucleocytoplasmic traffic induced by some RNA viruses. Virology (2000) 1.23
p53 modulation of anchorage independent growth and experimental metastasis. Oncogene (1996) 1.23
Forward genetics in mammalian cells: functional approaches to gene discovery. Hum Mol Genet (1999) 1.22
The primary and secondary structure of the 5'-end region of encephalomyocarditis virus RNA. A novel approach to sequencing long RNA molecules. Gene (1983) 1.20
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene (2008) 1.20
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points. Virology (1985) 1.18
Encephalomyocarditis virus-specific polypeptide p22 possessing a proteolytic activity: preliminary mapping on the viral genome. FEBS Lett (1979) 1.14
Proteolytic activity of the nonstructural polypeptide p22 of encephalomyocarditis virus. Biochem Biophys Res Commun (1981) 1.14
Gross rearrangements within the 5'-untranslated region of the picornaviral genomes. Nucleic Acids Res (1990) 1.13
Attenuation of Theiler's murine encephalomyelitis virus by modifications of the oligopyrimidine/AUG tandem, a host-dependent translational cis element. J Virol (1995) 1.13
Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem (1999) 1.12
Structural requirements of the higher order RNA kissing element in the enteroviral 3'UTR. Nucleic Acids Res (1999) 1.11
Biochemical evidence for intertypic genetic recombination of polioviruses. FEBS Lett (1980) 1.10
Bacillus methanolicus sp. nov., a new species of thermotolerant, methanol-utilizing, endospore-forming bacteria. Int J Syst Bacteriol (1992) 1.10
A model for rearrangements in RNA genomes. Nucleic Acids Res (1995) 1.10
Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet (1997) 1.08
The enhanced mutagenic potential of the MucAB proteins correlates with the highly efficient processing of the MucA protein. J Bacteriol (1992) 1.06
Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology (1995) 1.06
Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry (Mosc) (2000) 1.02
[Evolution of RNA-dependent RNA polymerases of positive riboviruses]. Mol Gen Mikrobiol Virusol (1987) 1.02
Neurovirulence of the intertypic poliovirus recombinant v3/a1-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome. J Gen Virol (1985) 1.02
Cell interaction and its role in mesoderm cell migration during Xenopus gastrulation. Dev Dyn (1992) 1.02
The structure of the covalent linkage between proteins and RNA in encephalomyocarditis virus. Nucleic Acids Res (1980) 1.01
Translation of tick-borne encephalitis virus (flavivirus) genome in vitro: synthesis of two structural polypeptides. Virology (1981) 1.01
Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol (2005) 1.01
Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology (1994) 1.01
Palindrome-like dimers of double-stranded RNA of encephalomyocarditis virus. Virology (1980) 1.01
Virus-specific proteins associated with ribosomes of Krebs-II cells infected with encephalomyocarditis virus. FEBS Lett (1974) 1.00
Circularity and cross-linking in preparations of replicative form of encephalomyocarditis virus RNA. J Mol Biol (1972) 1.00
p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene (2000) 1.00
Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res (1991) 0.99
Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus. Cancer Res (1997) 0.99
Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. Biochem Pharmacol (2001) 0.99
Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Oncogene (2006) 0.96
Comparative studies on the genomes of some picornaviruses: denaturation mapping of replicative form RNA and electron microscopy of heteroduplex RNA. Virology (1979) 0.96
Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology (1999) 0.96
Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus. J Virol (1992) 0.95
Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Virology (1995) 0.93
ART-CH: a VL30 in chickens? J Virol (1994) 0.93
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93
A comparative study on translation of flavivirus and picornavirus RNAs in vitro: apparently different modes of protein synthesis. FEBS Lett (1978) 0.93
Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein. Proc Natl Acad Sci U S A (2001) 0.93
Mechanism of resistance to enteroviruses of some primate cells in tissue culture. J Virol (1968) 0.90
Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res (1995) 0.90
Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR. RNA (2000) 0.90